Found 10 matching trials
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells N/A The goal of this clinical study is to learn more about the long-term safety...
Show More Status
Enrolling By Invitation
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma PHASE2 This phase II trial tests the effect of nemtabrutinib in combination with b...
Show More Location
Vanderbilt University/Ingram Cancer Center
Learn More & Join Trial
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia PHASE2 The goal of this clinical study is to learn more about KTE-X19, and how saf...
Show More Status
Active Not Recruiting
Location
Chiba University Hospital
Learn More & Join Trial
MT2017-45: CAR-T Cell Therapy for Heme Malignancies PHASE2 This is a phase II study of FDA-approved CAR-T products for patients with h...
Show More Status
Active Not Recruiting
Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel N/A The goal of this study is to provide access to brexucabtagene autoleucel fo...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL PHASE2 This is a phase 2, open-label, randomized, multicenter clinical trial in pa...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies N/A The primary objectives of this study are:
Cohort 1: to provide access to b...
Show More Status
Approved For Marketing
Location
Stanford Cancer Institute
Learn More & Join Trial
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) PHASE2 This is a Phase 2 Study is to determine the efficacy and safety rate of B-C...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) PHASE2 The goal of this clinical study is to test how well the study drug, brexuca...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) PHASE2 The goal of this clinical study is to test how well the study drug, brexuca...
Show More Location
Banner MD Anderson
Learn More & Join Trial